Research programme: antidepressants - Clera

Drug Profile

Research programme: antidepressants - Clera

Alternative Names: Clera 103; Clera 301; CLR 200

Latest Information Update: 21 Jan 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Clera
  • Class Small molecules
  • Mechanism of Action Dopamine uptake inhibitors; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Major depressive disorder

Most Recent Events

  • 21 Jan 2014 Discontinued - Preclinical for Major depressive disorder in Canada (PO)
  • 12 Jul 2010 Preclinical trials in Depression in Canada (PO)
  • 29 Jun 2004 This programme is available for licensing(
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top